Jennifer Weishaupt

Chris O’Brien Lifehouse

Papers

2

Total Citations

26

H-Index

2

About

Dr. Jennifer Weishaupt is a gynaecologic oncologist whose research focuses on advancing minimally invasive surgical techniques for the treatment of gynaecologic cancers, with a particular emphasis on improving outcomes for high-risk patient populations. Her most cited work, a 2020 study comparing robotic versus laparoscopic hysterectomy in morbidly obese women with endometrial cancer (24 citations), directly addresses the critical need for safer, more effective surgical approaches in this challenging cohort. This contribution has helped inform clinical decision-making for surgeons managing obese patients, a group disproportionately affected by endometrial cancer. Dr. Weishaupt has also contributed to the ongoing discourse surrounding the landmark LACC trial, evaluating surgical management outcomes for early-stage cervical cancer in an Australian single-centre study. By providing real-world data on the shift from open to minimally invasive radical hysterectomy, her work aids in contextualising global trial results within local practice. Through these investigations, Dr. Weishaupt demonstrates a commitment to refining surgical standards and personalising care, ultimately striving to enhance both oncologic safety and postoperative recovery for women with gynaecologic malignancies.

Research Focus

Key Achievements

2
H-Index
2
Papers
26
Total Citations
13
Avg Citations/Paper
🏆 Most Cited Paper
Robotic versus laparoscopic hysterectomy in morbidly obese women for endometrial cancer
24 citations · 2020
📈 Most Prolific Year: 2020 (2 Papers)
🤝 Key Collaborators: 4
🏛 Institutions: Chris O’Brien Lifehouse

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago